chrisvoncsefalvay/vaers-outcomes huggingface dataset:
both of his lower extremities (below knee) has muscle aches and pain; both of his lower extremities (below knee) has muscle aches and pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (both of his lower extremities (below knee) has muscle aches and pain) and MYALGIA (both of his lower extremities (below knee) has muscle aches and pain) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Cholesterol total abnormal NOS.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (both of his lower extremities (below knee) has muscle aches and pain) and MYALGIA (both of his lower extremities (below knee) has muscle aches and pain). At the time of the report, PAIN IN EXTREMITY (both of his lower extremities (below knee) has muscle aches and pain) and MYALGIA (both of his lower extremities (below knee) has muscle aches and pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: normal (normal) Normal.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications included high blood pressure medication and cholesterol medications.  Patient weight reported as 185. Patient had been to many specialists and  ruled out all other conditions. Patient visited neurologist, RA doctor, cardiologist, orthopedist.  They recommended patient to get physical therapy.   This case was linked to MOD-2022-505549, MOD-2022-505568 (Patient Link).
Information has been received from a registered nurse referring to multiple unspecified patients. From 28-FEB-2015 to 11-MAR-2015, the multiple unspecified patients were vaccinated with 0.5ml dose of PROQUAD (Merck) which post supported temperature excursion(s) (lot# and expiration date not provided), subcutaneously. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Generalized hives with scattered small blisters, per mom lasted only for 20 mins. Resolved by itself with no sequelae.
Vaccines administered on 10/18/13 in A.M. Diaphoretic and shaky by evening. Arm became swollen and red and developed rash. Reported seen at walk in clinic and ultimately admitted to hosp.
Patient was given undiluted Pfizer COVID vaccine, maroon cap, 6m-4y and was given a larger (0.3 mg) dose than she should have recieved.
Pt is 5 days post finishing oral typhoid. Had cramping but last night had 4 episodes of blood tinged diarrhea. No fever. 5/11/05 saw Doctor today, no diarrhea, stool Guaiac negative.
She fainted, unwitnessed, shortly after. She then moved to another location and sat while we brought her water. She was very pale and sweaty and slow in response time. She asked for paper towels. She said she would call her mom to come get her. About 5 minutes later, she started to fall forward and to the side with her eyes open and was unresponsive. (She was sitting in a chair at this time). I shook her and asked her repeatedly if she's ok.  Finally after about 8 seconds, she responded with "yes" and then seemed to snap to. We called 911 after this episode.  By the time they came, her color had returned and she seemed ok.  They let her leave with her mom.
Given 1st GARDASIL 1/7/09 at routine health assessment Patient seen in the office on 2/5/09. Developed lump in her neck on 2/2/09. Diagnosed with goiter. Thyroid testing - T4, T3, TSH normal. Thyroglobulin Ab - negative Has euthyroid goiter.
mild rash on the front of her torso; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number and Expiration date were not reported), via an unspecified route of administration on 23Feb2021 as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced mild rash on the front of her torso on an unspecified date. The patient was asking if the side effect has been reported and if developing a rash after the second dose of the Pfizer COVID-19 vaccine would be a contraindication to any future booster shots created for variants strains that are created. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
NAUSEA, ITCHING, ACHY JOINTS, TIGHT ARM, HOT ARM.
sorry both time i got mine i got the flu so no thx; Initial information received on 19-Oct-2023 regarding an unsolicited valid Social Media non-serious case received from a Patient.  This case involves an unknown age and unknown gender patient who reported sorry both time i got mine i got the flu so no thx after receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect Influenza Vaccine produced by unknown manufacturer (lot number, strength, dose, expiry date, form not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date the patient reported sorry both time i got mine i got the flu so no thx (influenza) (unknown latency) following the administration of Influenza Vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored doses of (Merck) PROQUAD (Lot: L002419 exp: 23-JUL-2016, Lot: K020749 exp: 30-APR-2016, Lot: K022447 exp: 13-MAY-2016 respectively; strength, dosage and route unspecified. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected because the physician did not want to be contacted.
Seconds after administering the vaccines, some blood starting coming out of the injection site, followed by swelling of the surrounding area of the arm.  The skin around the injection site of the left arm rose noticeably, and bulged out.  Gave patient ice pack for swelling and had patient sit for 15 minutes.  Patient reported no systemic symptoms.  After 15 minutes, patient informed they were feeling better and left the pharmacy.  Patient informs he would check in with his doctor regarding this adverse reaction and get it looked at.  Unable to currently contact patient regarding if he made and appointment.
pt recv vax; turned pale & diff to arouse approx 20 mins p/ vax;
chills left breast lymph nodes were sore lymph nodes in neck below jaw swollen esophagus felt inflamed gut felt inflamed itchy scalp itchy legs and butt giant red blotch where injection was, it   was hot, swollen and itchy
Medical history included no adverse events following receipt of previous influenza virus vaccine and  no adverse events following receipt of previous unspecified vaccinations. The subject received no other vaccinations on the day of the FLULAVAL administration. This case was reported by a healthcare professional and described the occurrence of stiff neck in a 90-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On an unspecified date the subject received 1st dose of FLULAVAL (.5 ml, unknown). Within hours of vaccination with FLULAVAL, the subject experienced stiff neck and restricted neck movement. The healthcare professional considered the events were disabling. At the time of reporting the outcome of the events were unspecified. The healthcare professional (a pharmacy coordinator) reported that a 90 year old male received FLULAVAL and the next morning reported neck stiffness. this required him to move his head with his hands, he could not  turn his neck. The dates of administration and onset were not known at the time of this report. Caller reports that the subject will be, if he hasn't already seen, a Chiropractor.
8.5 weeks pregnant; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of PREGNANCY (8.5 weeks pregnant) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 20B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS) for Morning sickness, ASCORBIC ACID, FERROUS FUMARATE, FOLIC ACID, RETINOL (PRENATAL [ASCORBIC ACID;FERROUS FUMARATE;FOLIC ACID;RETINOL]) for Vitamin deficiency.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 27-Nov-2021. On 13-Feb-2021, the patient experienced PREGNANCY (8.5 weeks pregnant). At the time of the report, PREGNANCY (8.5 weeks pregnant) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
My COVID-19 symptoms started on 02/28/2023 in the afternoon. I  had a sore throat, cough, chest congestion, abdominal pain, fever, nausea, and severe fatigue.  On 03/01/23023 I did a COVID-19 home test which was positive. I called my doctor's office right away and set up a telehealth with my doctor. She prescribe me Paxlovid and gave me refill for Albuterol.  After 8 days  later  on 03/08/2023  I tested negative.
The day after the shot--fever, very tired all day.  Very tired the second day after the shot.
No adverse event; Patient received moderna covid-19 vaccine bivalent by subQ injection; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient received moderna covid-19 vaccine bivalent by subQ injection) and NO ADVERSE EVENT (No adverse event) in a 66-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 042H22A) for COVID-19 prophylaxis.     It was unknown patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (1st dose), PFIZER BIONTECH COVID-19 VACCINE (booster dose) and PFIZER BIONTECH COVID-19 VACCINE (2nd dose). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 13-Dec-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Subcutaneous) .5 milliliter. On 13-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient received moderna covid-19 vaccine bivalent by subQ injection). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient received moderna covid-19 vaccine bivalent by subQ injection) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Subcutaneous), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient received moderna covid-19 vaccine bivalent by subQ injection).    No concomitant medication was provided.  It was reported that error occurred because the wrong sized needle was used for the injection.  Treatment medication was not provided by the reporter.
21APR92 swelling glands in neck; could hardly talk; 23APR92 itching-rash on face, chest, arms-rash started on chest 7 days;
Systemic: Fainting / Unresponsive-Mild, Additional Details: The patient has a long history of fainting with vaccines but she did not tell us this. We gave her the moderna vaccine and she seemed fine. As we were about to inject the Flu vaccine she fainted. She was fine right away though. She stayed for 30 minutes and drank water.
This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021 at 11:02 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 07-Jan-2021 at 11:02 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Age was reported as 69.50. No concomitant product reported by reporter. The reported condition of the vial was not frozen. Vaccine was moved to fridge on 05-Jan-2021, Vaccine was moved to clinic on 07-Jan-2021. Number of vials sent to clinic were 06 and Total doses given for the day were 96. Vaccine underwent temperature excursion on 07-Jan-2021 till 35 degrees Fahrenheit at 10 AM and 9 AM and Best Use Date for the vaccine was 27-Jan-2021. It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F. Vial was punctured right before administration. No treatment medication reported by reporter.
He was walking funny: His legs were going all the way up and coming back down.; Exhausted; Not get his muscles to respond; Stomach and thighs had a full rash; Fever; So sick; Gold tooth which he got 6 months ago, started to hurt; Mouth sores; This is a spontaneous report from a contactable consumer or other non hcp (patient) via Medical information team. A male patient of an unspecified age received second dose of bnt162b2 (BNT162B2, solution for injection, Lot number was not reported), via an unspecified route of administration on 13Feb2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient historical vaccine includes first dose of COVID vaccine (BNT162B2, solution for injection) on unspecified date for COVID-19 immunization and experienced arm soreness (These side effects were only after the 2nd dose. Following the 1st dose, he had arm soreness but nothing like this). The patient experienced that he was walking funny his legs were going all the way up and coming back down, patient was wondering if it may have been neurologic, exhausted, not get his muscles to respond, stomach and thighs had a full rash, fever, so sick, gold tooth which he got 6 months ago, started to hurt, and mouth sores on an unspecified date in 2021. The patient underwent lab tests and procedures which included pyrexia with unknown results. The outcome of the events was unknown.  Information on the lot/batch number has been requested.   Follow-up attempts are completed. No further information is expected.
10mins p/vax lt @ shot site was red &swollen w/red blotches on both legs; waited 30mins @ ofc redness & swelling disappeared & pt returned home; @ 2PM pt returned to ofc w/red blotches on face, neck & upper abd; pt recv DPH
Immunization was given after 12-8-22. Moderna manufacturer was notified and case # MI-00003113 was assigned. The Lot of AS7166B was tested and found per Moderna the vaccine DID have the necessary activity to protect against the SARS-CoV-2 virus at the time of administration. Patient and patient's PCP notified.
Patient came in and complained about weakness and dizziness over 1 week. Asked to call 911.  She sated for 5 minutes in the waitting room and her husband came to take her to ER.
Within three to four hours of receiving the Moderna vaccine my stomach started to become uneasy. I thought it might have been what I ate for lunch after the shot but I started to have diarrhea and vomiting. While I was in the bathroom experiencing both I passed out and hit my head on the floor. My wife called 911 and was checked by the responding paramedics; my vitals were good and I did not feel the need to be transported to the hospital. Throughout the night I had chills and continued to throw up and experience diarrhea.
about 2 hoursafter receiving the vaccine I started to get a headache.  My right arm was sore, as was expected from the injection.  Towards the end of the day about 10 pm I started getting the chills and was very tired.  This lasted until Friday the 21st of Feb.  on Thursday evening Feb 20  20200 I started experiencing extreme stomach cramping for several hours. I had no vomitting or loose stool.  The stomach cramps started around 7pm at night and ended about 3am on 02/21/2020.  I did not go to urgent care.  At 7pm at night on 02/21/2020 I am feeling still tired and have muscle soreness but headache and stomach cramping are gone.
his wrists, hands, and knees started swelling, his doctor said it was arthritis; This is a spontaneous report from a contactable consumer (patient). A 70-year-old male patient received BNT162B2 (COMIRNATY, Solution for injection; Lot Number: EN6200 and expiry date not reported), via an unspecified route of administration, on 19Feb2021 (at the age of 70-year-old), as dose 1, single, for COVID-19 immunisation. Medical history included ongoing arthritis which started since he was in his 20's and COVID-19 in the first week of Mar2020. The patient's concomitant medications were not reported. On 19Feb2021, the patient received first dose of COVID vaccine, and he sat for 15 minutes and had no reaction, but 3 days later (22Feb2021), his wrist started swelling and hands and it went to his knees. He went back to care provider on 06Mar2021, and his hands were like baseball mitts. He could not move his hands or fingers. His doctor took X-rays and said he had arthritis. The patient went to 2 nerve specialist and they said he had a reaction to the vaccine. The patient was supposed to get second vaccine on 12Mar2021, but his hands were swollen for 2 months. It took that long for them to go down. He went back when he got better to see if he could get the second shot. It was reported that, he got the email from Pfizer not to get second vaccine though. His doctor said she was not clearing him to get second dose. The patient wanted to know how he could get cleared to get vaccine and if he has to start over again and if it would still be okay to get the 2nd dose even if it has been so long. The patient also wants to know if Pfizer would recommend him to get the Moderna or the Johnson & Johnson Covid-19 Vaccine instead of the Pfizer-BioNTech Covid-19 Vaccine even if he was already had his 1st dose of the Pfizer Covid-19 Vaccine. The outcome of the event was unknown.  Follow-up attempts completed. No further information expected.
PATIENT CALLED TODAY 4/26/21 CONCERNED ABOUT THE SECOND SHOT IN THE MODERNA VACCINE SERIES.  HE STATED THAT AFTER THE FIRST DOSE ON 4/20/21 HE EXPERIENCED A FEELING OF BEING OVERWHELMED THAT LASTED ABOUT 3 HOURS.  HE FELT A SENSATION OF THROAT AND LIP SWELLING, TINGLING OF THE TONGUE AND FEELING OF DISCOMFORT. PATIENT STATED THAT HE HAS HAD REACTIONS TO POLYETHYLENE GLYCOL IN THE PAST.
Pt had convuls & t104 admitted to hosp; Mom stated that 2 days p/d/c from hosp pt devel roseola x 1 2/2 days;
Pt received Anthrax vaccine #4. Three days post vax, the pt experienced redness and pruritus at the injection site with 3 cm induration and erythema.
veins in temple swollen noticeably for 2 days, swooshing in my head, ringing in my head, hands get really red and my forearm veins are noticeably swollen at times.
Initial and follow up information has been received from a pharmacist concerning a 76 year old female patient who on 26-JUL-2007 at 11:00 was vaccinated SC in the right upper arm with a single first dose of Zostavax (Oka/Merck) (Lot#658081/0743U).  Subsequently the patient developed redness, itching, soreness, and swelling after the vaccination.  Unspecified medical attention was sought.  The pharmacist advised the patient to take BENADRYL 25 mg.  The patient did and after 24 hours the symptoms resolved.  No further information was provided.  There was no product quality complaint involved.  Additional information is not expected.
PATIENT CALLED STATING THAT HE'D NOTICED 2 RED SPOTS ON HIS ARM APPROXIMATELY 2 WEEKS AFTER RECEIVING THE SHINGLE VACCINE. HE SUGGESTED THAT IT MAY BE SHINGLES THAT HE'S CONTRACTED AS A RESULT OF RECEIVING THE VACCINE. I ASKED THE PATIENT IF HE'D POSSIBLY BEEN STUNG OR BITTEN BY AN INSECT OR IF IT'S POSSIBLE THAT HE HAS BEEN IN CONTACT WITH SOMETHING THAT HE'S ALLERGIC TO. HE SAID THAT NEITHER OF MY SUGGESTIONS WERE THE CASE. I INFORMED THE PATIENT TO REPORT TO THE NEAREST ER OR URGENT CARE IF HIS SYMPTOMS PERSIST FOR A PROPER DIAGNOSIS.
pt recvd vax 5JUN95 & 23JUN95 pt devel low grade fever, h/a, myalgias;25JUN95 pt broke out in maculopapular rash;on exam pt had approx 20 varicelliform lesions on chest & abd;shell viral culture of lesions was positive for varicella virus;
Flu-like achiness and diffuse pain from the waist up starting the evening of the vaccine and continuing for the next 2 days.
Was 28 week pregnant at time Started with seeing lights in my eyes and being light head a few mins after getting the shot. About 30 mins later I started throwing up, cold sweats and headache(was very sensitive to light or noise) . The symptoms continued for 48 hours.
patient developed a rash the day after the vaccination and it has continued to spread, almost to the elbow
I did not have an adverse reaction to the vaccine. On 10/28/2022, I began not feeling well with symptoms of a flu. These symptoms have been going on and off since the vaccine. After about two weeks of the symptoms, I went to the doctor. I have had a lot of coughing which gave me chest pain. I was given two prescriptions to help with my symptoms and it did not help. As of today, I continue to have the symptoms.
Approx 7 hours after receiving the vaccine, my blood pressure dropped significantly. I had an overwhelming feeling as if I was going to pass out and had a pins & needles feeling in my face. I checked my bp and it was 102/70. Over the course of about 40 minutes it slowly went back up and was at 136/84 the last time I took it last night.  I reached out to my pcp to let her know and to see if getting the second dose was safe. She confirmed she believes it was a side effect of the vaccine, but it was safe to get the second dose in 3 weeks.